Explore health content from A to Z.
I need information about...
(DALLAS, TEXAS, Oct. 1, 2009) – The Baylor Charles A. Sammons Cancer Center has become a full member of one of the largest cancer clinical trials cooperative groups in the United States. Funded by research grants from the National Cancer Institute, Southwest Oncology Group conducts clinical trials to prevent and treat cancer in adults, and to improve the quality of life for cancer survivors.
“Joining this prestigious group will allow us to offer additional, important clinical trials to cancer patients in North Texas,” said Alan M. Miller, M.D., Ph.D., medical director of the Baylor Sammons Cancer Center and chief of oncology for Baylor Health Care System. “We are honored to partner with our colleagues throughout the country and world in participating in clinical trials that are making great progress in the fight against cancer,”
Miller serves as principal investigator for the Baylor site.
Southwest Oncology Group has more than 5,000 affiliated physician researchers participating at 516 institutions in the United States, Canada, Puerto Rico, Sweden and Saudi Arabia. The group conducts large Phase III trials, such as an ongoing prostate cancer prevention study with more than 35,000 men enrolled as well as a newly opened trial in women with breast cancer to test the effectiveness of three drugs in preventing or delaying metastasis to the bone.
Southwest Oncology Group also conducts groundbreaking Phase I and Phase II studies to test new targeted therapies and tissue studies that put to work the latest discoveries in cancer genetics.
Baylor Sammons Cancer Center’s membership in the group is another step towards Baylor University Medical Center at Dallas’ goal of becoming a nationally and internationally renowned cancer care destination.
Copyright © 2015 Baylor Health Care System All Rights Reserved. |
3500 Gaston Avenue, Dallas, TX 75246-2017 | 1.800.4BAYLOR